Breaking News on Contract Research, Manufacturing & Clinical Trials

GPCM 2014 London

Strategic partners, controlling the supply chain and what happens when something goes wrong, were just three of the subjects discussed at this year's Global Contract Manufacturing summit - Europe’s largest and leading event for the contract manufacturing community - in London, UK.


Polymers make you go faster, greener, say BASF and Colorcon

20-Oct-2014 - BASF, one of the world’s largest chemical companies, has chosen Colorcon to distribute its Kollicoat Immediate Release (IR) tablet coatings.

Strategic partnerships driving consolidation of CDMO industry, says report

24-Jul-2014 - Growth of Pharma strategic partnerships with contract development and manufacturing organisations (CDMOs) is driving consolidation, according to an industry report.

Big Pharma's 'intellectual arrogance' stunts CMO partnerships, says GPCM Chair

22-Jul-2014 - Efficient relationships with contract manufacturers are being held back by Big Pharma’s ‘intellectual arrogance’ and ill-defined operational teams, according to an ex-Director at GlaxoSmithKline.

Consultant: For CMO selection, its the (molecule) size that counts!

16-Jul-2014 - The complex nature of biopharmaceuticals dictates the choice of contract manufacturer when compared with selecting a partner for small molecule drugs, according to a life sciences consultant.

CMO quality audits: necessary and beneficial to all, says consultant

10-Jul-2014 - A quality assurance audit is as beneficial to the CMO as it is to the sponsor selecting a third-party manufacturer, according to an ex-Merck Serono and MHRA consultant.

Russia set for first foreign CMOs as pharma preps for 2020 policy

09-Jul-2014 - Several international CMOs will establish themselves in Russia over the next few years as pharma looks to satisfy the country's manufacturing policies, the CEO of R-Pharm predicts.

Big Pharma Insourcing replacing Asian suppliers as competition for western CMOs

23-Jun-2014 - Hidden costs and quality issues have encouraged pharma to abandon China and India, but Western CMOs are now under threat from a return to in-house manufacture, says a procurement consultant

Dispatches from the GPCM Conference, London, UK

For big pharma, ten is the magic number of CMOs says ex-GSK Director

18-Jun-2014 - Big pharma is moving towards strategic partnerships with CMOs, according to speakers at the Global Pharmaceutical Contract Manufacturing (GPCM) Conference, with the ideal number of partners being ten.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...